Monte Rosa Therapeutics, Inc.
GLUE· Nasdaq
Monte Rosa Therapeutics, Inc.
- Last sale
- Oct 1, 2026 · -5.50%
- Market cap
- $960.63M
- 85.31M shares
- Filings
- 398
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $141,500,000 | reported | |
| FY 2024 | 2024-12-31 | $121,563,000 | reported | |
| FY 2023 | 2023-12-31 | $111,272,000 | reported | |
| FY 2022 | 2022-12-31 | $85,061,000 | reported | |
| FY 2021 | 2021-12-31 | $57,155,000 | reported | |
| FY 2020 | 2020-12-31 | $24,005,000 | reported |
Monte Rosa Therapeutics, Inc. · CIK 1826457 · Engraved from SEC EDGAR
